Slides
Page 1
Merrill Gray – MD & CEO Investor Webinar FY 2026 Results 30 SEPTEMBER 2026
Page 2
INVESTOR WEBINAR | 30 SEPTEMBER 2026 | ©AnteoTech Limited 2 Disclaimer IMPORTANT INFORMATION The purpose of the presentation is to provide an update of the business of AnteoTech Ltd (ASX: ADO) (AnteoTech). These slides have been prepared as a presentation aid only and the information they contain may require further explanation and/or clarification. Accordingly, these slides and the information they contain should be read in conjunction with past and future announcements made by AnteoTech and should not be relied upon as an independent source of information. Please contact AnteoTech and/or refer to the Company's website for further information. The views expressed in this presentation contain information derived from publicly available sources that have not been independently verified. No representation or warranty is made as to the accuracy, completeness or reliability of the information. Past performance is not indicative of future performance. FORWARD-LOOKING STATEMENTS The presentation may contain certain “forward-looking statements”. Forward-looking statements can generally be identified by the use of forward-looking words such as “may”, “will”, “would”, “could”, “expect”, “intend”, “plan”, “aim”, “estimate”, “target”, “anticipate”, “believe”, “continue”, “objectives”, “outlook”, “guidance” or other similar words, and include statements regarding AnteoTech's intent, belief or current expectations with respect to AnteoTech’s business and operations, market conditions, results of operations and financial condition, capital adequacy and risk management. These forward-looking statements should not be relied upon as a representation or warranty, express or implied, as to future matters. Prospective financial information has been based on current expectations about future events and is, however, subject to risks, uncertainties, contingencies and assumptions that could cause actual results to differ materially from the expectations described in such prospective information. AnteoTech disclaims any obligation to update any forward-looking statement to reflect events or circumstances after the date of the presentation, subject to the disclosure requirements applicable to the Group. NOT AN OFFER OF SECURITIES This presentation should not be relied on as a recommendation or forecast by AnteoTech. Nothing in this presentation should be construed as either an offer to sell or a solicitation of an offer to buy or sell shares in any jurisdiction. The information in this presentation is not intended to be relied upon as advice to investors or potential investors and does not take into account your financial objectives, situation or needs. Investors should consult with their own legal, tax, business and/or financial advisors in connection with any investment decision. AnteoBind NXT, Anteo X®, Anteo S and Ultranode® are trademarks of AnteoTech. The use of registered and pending trademark symbols throughout the presentation is implied. All $ quoted are AUD unless otherwise stated.
Page 3
INVESTOR WEBINAR | 30 September 2026 | ©AnteoTech Limited 3 Today’s Agenda • Company Overview • FY2026 Financial Performance • FY2026 in Review • What Next? • Questions
Page 4
INVESTOR WEBINAR | 30 SEPTEMBER 2026 | ©AnteoTech Limited 4 One proprietary chemical platform Two global markets Multiple commercial pathways Technology p rotected through 17 granted patents C O M P A N Y O V E R V I E W Advanced Battery Technologies Ultranode 70, 95, X Anteo X Anteo S Anteo C SiMRAX Life Sciences AnteoBind / AnteoBind NXT • Lateral Flow • Multiplex • CLIA • ELISA FY2026 Annual Report released
Page 5
INVESTOR WEBINAR | 30 September 2026 | ©AnteoTech Limited 5 Capital Structure and Corporate Overview Share Price – 6 months to 23 Sept 2026 Directors Glenda McLoughlin Non-Executive Chair Investment Banker with Morgan Stanley, Credit Suisse and Barclays. Commercial Advisor and ASX Founder. Energy and Infrastructure sector expertise. Dr. Geoff Cumming Non-Executive Director Career spanning research to sales and marketing and Executive roles with Roche Also on INOVIQ Ltd (IIQ) Board. Biotechnology and Healthcare sector expertise. Merrill Gray Managing Director/CEO Appointed 19 August 2025 (NED, 30 Jan., Interim MD 18 April 2025). ASX Founder and MD/CEO. Energy incl. Battery (CAM (LFP/LMFP), Graphite and Recycling) plus Hydrogen and Renewables experience. Capital Structure (as at 23 September 2026) Shares Unlisted Options 3,265.1 million 233.5 million (7% expire in 2026, 65% in 2028). Employee/Director options 39% Market Capitalisation $56 m as at 23 September 2026 Top 20 Holders Hold 20% of shares Cash in Bank $11.2 million total as at 30 June 2026 C O M P A N Y O V E R V I E W Source: https://www.asx.com.au/markets/company/ADO
Page 6
INVESTOR WEBINAR | 30 September 2026 | ©AnteoTech Limited 6 L I F E S C I E N C E S
Page 7
INVESTOR WEBINAR | 30 SEPTEMBER 2026 | ©AnteoTech Limited 7 Leading in High Silicon Anode Technology A D V A N C E D B A T T E R Y T E C H N O L O G I E S INVESTOR WEBINAR| 30 September 2026 | ©AnteoTech Limited 7 Leading in Cross -linking Performance Additive Cross-linker for Ceramic Coated Separators (CCS) ANTEO S S Cross-linker for Silicon Anodes ® Anteo X + SWCNT Combination Product SiMRAX Cross-linker for Primer Coatings on Current Collector Foils ANTEO C C
Page 8
INVESTOR WEBINAR | 30 SEPTEMBER 2026 | ©AnteoTech Limited 8 Continued delivery on FY2026 Strategy Source: Refer ASX Release dated 10 June 2025 “Strategic Review Outcomes” Existing markets where opportunities will continue to be pursued New opportunities being targeted and pursued Strategy Europe • Targeted sales growth through existing network expanding commercialisation pipeline. • Securing of strategic partnerships, profit repatriation model basis. India • Further expand Serum Institute of India relationship and secure additional similar customers. • Work with Austrade and Trade and Investment Queensland (TIQ) • Target E-Mobility and Wearables manufacturers • Joint Venture and Joint Product Development (JDA). USA • Expansion of our customer base • Attract strategic partner • Target the Point-of-Care Diagnostics, CLIA and ELISA markets. • Target defence and security via drones and Unmanned Aerial Systems (UAS). • Carbon Nanotube JDA. South Korea & Japan • Expand our customer base/sales • Attract strategic partners • Distributors supporting growth • Austrade and TIQ support • Distributors supporting growth • Austrade and TIQ support • Expand existing customer base • Attract new partners • Global Life Sciences company engagement lateral flow, CLIA and ELISA. • WYON evaluation and validation and new customers Life Sciences 1 Advanced Battery Technologies C O M P A N Y O V E R V I E W Global Diagnostic immunoassays market: US$56 B p.a. sales revenue , 9% CAGR (2024) 1,2 1 =Source: Markets and Markets May 2025 In Vitro Diagnostic Market: Growth, Size, Share and Trends and Confidential Pharmaceu tic al company 2= Precedence Research, Coherent Market Research 3 =https://www.researchandmarkets.com/reports/6089608/ceramic -coated -separators -market -global 4 = Refer 30 June 2026 ASX Announcement – New Product - Anteo C – Launched, Tested and Shipped etc. High silicon anode market: US$540 M growing at 45% CAGR (2025) Ceramic coated separators (CCS): US$2 B growing at 21% CAGR (2024) 3 Collector Foils: US$21 B, Primer coatings/Anteo C ppt of this.
Page 9
INVESTOR WEBINAR | 30 SEPTEMBER 2026 | ©AnteoTech Limited 9 Further progress against Strategy • 5-Year US $1.8m contract with Serum Institute of India (SII) • AnteoBind NXT activated ELISA plate prototype under evaluation by SII • Local BD resource • South Korea: - Xerabrid ABT, 2026 - Kangshin ABT, 2025. - KOMA, LS 2015 • Japan: - Cosmo Bio, 2026 Black Diamond Structures joint product SiMRAX in customer trials Wyon evaluation of Ultranode 70 in commercial cell format2 x Ultranode 95 Drone anode JDAs under negotiation • Large Life Sciences company collaboration CLIA • Local BD resources • Battery Innovation Center (BIC) Ultranode 95 commercial scale-up validation program – MLP, cylindricals • Local BD resource Existing sales and growth New growth markets Anteo S Anteo C C O M P A N Y O V E R V I E W
Page 10
INVESTOR WEBINAR | 30 September 2026 | ©AnteoTech Limited 10 Sales Revenue F Y 2 0 2 6 F I N A N C I A L P E R F O R M A N C E 460,397 968,878* 467,589^ 0 200,000 400,000 600,000 800,000 1,000,000 1,200,000 FY2024 FY2025 FY2026 [A$] Note: * FY2025 included an additional Serum Institute of India (SII) payment of $276,863 ^ A further $134,138 sale to SII was completed on 7 July 2026 and will be recognised in FY2027
Page 11
INVESTOR WEBINAR | 30 September 2026 | ©AnteoTech Limited 11 Total Revenue F Y 2 0 2 6 F I N A N C I A L P E R F O R M A N C E 0 500,000 1,000,000 1,500,000 2,000,000 2,500,000 3,000,000 3,500,000 4,000,000 4,500,000 5,000,000 FY2024 FY2025 FY2026 Sales Other income (e.g. R&D tax rebate and interest) 4,346,185 3,458,728 3,129,144 [A$] Note: A further $134,138 sale to SII was completed on 7 July 2026 and will be recognised in FY2027
Page 12
INVESTOR WEBINAR | 30 September 2026 | ©AnteoTech Limited 12 Operating Expense Reduction F Y 2 0 2 6 F I N A N C I A L P E R F O R M A N C E 10,892,231 8,451,114 6,857,881 0 2,000,000 4,000,000 6,000,000 8,000,000 10,000,000 12,000,000 FY2024 FY2025 FY2026 [A$] Note: Excluding non-cash items such as depreciation and amortisation and share based payments
Page 13
INVESTOR WEBINAR | 30 September 2026 | ©AnteoTech Limited 13 Losses F Y 2 0 2 6 F I N A N C I A L P E R F O R M A N C E -10,000,000 -9,000,000 -8,000,000 -7,000,000 -6,000,000 -5,000,000 -4,000,000 -3,000,000 -2,000,000 -1,000,000 0 FY2024 FY2025 FY2026 Note: A further $134,138 sale to SII was completed on 7 July 2026 and will be recognised in FY2027 -6,759,135 [A$] -5,375,654
Page 14
INVESTOR WEBINAR | 30 September 2026 | ©AnteoTech Limited 14 Commercialisation Focus Product and technology value proposition clarification and messaging Product and technology validation: Independent and in-house • ABT – Ultranode 95 at BIC, Ultranode X in-house >850 mAh/g, 1,020 cycles at 80% capacity retention), Ultranode 70 commercial cell format validation by Wyon. • LS – White Paper (2) in-house Expanded Product portfolio - Market demand led • ABT – SiMRAX, Anteo S , Anteo C • LS – CLIA, ELISA Significantly increased total addressable market: +$US60 B Multiple sales channels activated • Partnerships, BD facilitators, Distributors • Conferences: Face to face customer engagement • Digital marketing campaigns • CRM and Sales team in place Record samples under evaluation F Y 2 0 2 6 I N R E V I E W Better quality picture
Page 15
INVESTOR WEBINAR | 30 September 2026 | ©AnteoTech Limited 15 Growing Commercial Pipeline Number of Companies @ 7 September 2026 F Y 2 0 2 6 I N R E V I E W
Page 16
INVESTOR WEBINAR | 30 SEPTEMBER 2026 | ©AnteoTech Limited 16 FY2027 Priority: Sales Conversion Life Sciences Advanced Battery Technologies Corporate • Convert customer evaluations into sales - India, US, Europe, Japan and South Korea • Progress CLIA strategic partnerships and market entry • ELISA market entry • Progress US Military drone Ultranode 95 JDAs - High powered batteries • Convert Anteo S , Anteo C and Anteo X® sales including in SiMRAX • Progress Ultranode 70 commercial cell format evaluation and Consumer battery market opportunities • Build out Airspeeder supply collaboration/partnerships • Maintain financial discipline • Support sales pipeline conversion • Progress Strategic Partnerships • R&D tax rebate claim Cross Linker W H A T N E X T ?
Page 17
INVESTOR WEBINAR | 30 September 2026 | ©AnteoTech Limited 17 Upcoming Commercial Engagement W H A T N E X T ? MEDICA, Dusseldorf, Germany North American Battery Show 12-15 October 2026 Detroit, USA National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar (Mohali), Punjab, India
Page 18
Contact: Merrill Gray investors@anteotech.com +61 (07) 3219 0085 www.anteotech.com Questions
Page 19
INVESTOR WEBINAR | 30 SEPTEMBER 2026 | ©AnteoTech Limited 19 Electrochemical unit schematic plus electrolyte Anatomy of a Lithium-ion Battery (LIB) ANODE (-) CATHODE (+) Discharging the battery e- Li+ Copper foil (current collector): Anteo C used here Anode material coating: graphite, silicon – Anteo X , SiMRAX & Ultranode used here – binders and additives Separator (porous Polypropylene or Polyethylene) – Anteo S used here Cathode material coating: NCM, LFP, LCO or Advanced materials, binders and additives Aluminium foil (current collector) Anteo C used here A D V A N C E D BATTERY T E C H N O L O G I E S
Page 20
INVESTOR WEBINAR | 30 SEPTEMBER 2026 | ©AnteoTech Limited 20 The Drone, M/UAV and eVTOL Battery Market A large market with several very different use or end application cases HIGH CYCLE LIFE LOW ENERGY INTERMEDIATE CYCLE LIFE MEDIUM ENERGY LOW CYCLE LIFE MAXIMUM ENERGY ULTRANODE 95 Target Agricultural, Construction and Industrial Drones Logistics and Cargo Drones Short Endurance to Long Endurance ISR Drones + High Energy Cargo Drones + M/UAV & eVTOL A D V A N C E D B A T T E R Y T E C H N O L O G I E S
Page 21
Ultranode 95 – Superior Energy and Flight Time. High capacity and cost-effective anode technology Lowest $/kWh silicon active material Highly cost -effective anodes Superior Wh/kg at anode/cell level >2,400mAh/g of anode coating capacity possible At cell level, Specific Energy (Wh/kg) of >390 possible Supply chain security Existing silicon raw material supply from US,KR, EU Highly customisable Ultranode 95’s unique Value Proposition A D V A N C E D B A T T E R Y T E C H N O L O G I E S INVESTOR WEBINAR| 30 September 2026 | ©AnteoTech Limited 21
Page 22
INVESTOR WEBINAR | 30 SEPTEMBER 2026 | ©AnteoTech Limited 22 Anteo S A D V A N C E D B A T T E R Y T E C H N O L O G I E S • Anteo S is used in ceramic coatings on separators to: - Improve thermal stability - Reduce thermal runaway and fires - Improve puncture resistance • Anteo S potential lies in high volume sales for ESS and EVs Escondido, California (September 2024): A BESS fire at a substation resulted in significant damage. The incident involved overheating of battery cells. Source: https://eticaag.com/thermal -runaway -in -battery -energy -storage -systems -bess/ 51.0% 13.0% 24.0% 7.0% 4.0% 1.0% Separator use by end application (2032) Automotive (EV/HEV) Consumer electronics Energy storage (ESS) Industrial & transport Defence & aerospace Medical Source: Grand View Research (2024) - Battery Separator Market Size, Share & Trends Analysis Report by Material, by Application, by region, and Segment Forecasts, 2024 –2032 and IDTechEX (2024) - Li -ion Battery Separator Technologies and Markets 2024 –2034 Strategic Collaboration and Sales Agreement with
Page 23
INVESTOR WEBINAR | 30 SEPTEMBER 2026 | ©AnteoTech Limited 23 Application Automotive & eVTOLs 3C Markets and Micro-mobility M/UAS, eVTOL, Drones and Defence Ultranode technology Ultranode® X Ultranode® 70 Ultranode® 95 Cycle life High (>1,000 @ 80%) Medium (>500 @ 80%) Medium (>200 @ 80%) Coating capacities Medium (700-1,100 mAh/g) Medium (700-1,100 mAh/g) High (1,800-2,400 mAh/g) Supply Chain Options Korea, China, US Korea, China, US Korea, China, US Commercially scaled-up Engagement pathway 1. Technology partnership 2. Joint Development Agreements 3. Licensing 1. Ultranode samples 2. Ultranode + Cathode sample packs Ultranode samples and Ultranode + Cathode sample packs Leading in High Silicon Anode Technology A D V A N C E D B A T T E R Y T E C H N O L O G I E S INVESTOR WEBINAR| 30 September 2026 | ©AnteoTech Limited 23
Page 24
Leading in Cross -linking Performance Additive A D V A N C E D B A T T E R Y T E C H N O L O G I E S INVESTOR WEBINAR | 30 September 2026 | ©AnteoTech Limited 24 Cross-linker for Ceramic Coated Separators (CCS) ANTEO S S Cross-linker for Silicon Anodes ® Anteo X + SWCNT Combination Product SiMRAX Safer and Thinner Separators • Reinforces ceramic coating, reducing potential thermal runaway and fires. • Improves mechanical strength, puncture strength and thermal shut-down window Improved Performance • Improved cycle life/capacity retention • Reduced anode expansion Improved Cost Efficiency • Reduction in CNT content for high silicon anodes • Reduction in binder content for high binder systems All-in-one solution for high Si anodes • The only additive combining high quality carbon nanotube products with unique cross-linking agents • World’s most efficient binder strengthening additive. A single ‘drop in’ product that improves performance and reduces costs Cross-linker for Primer Coatings on Curren Collector Foils ANTEO C Improved Performance Enabled by • Improved metal foil adhesion • Reduced interphase resistance Improved Cost Efficiency • Cheaper binders • More water-based design choices C